Epidemiology, incidence, and mortality of leukemia in children early infancy to 14 years old of age in south-central Asia: A global ecological study by Khazaei, Z. et al.
Uncorrected Proof
J Compr Ped. In Press(In Press):e82258.
Published online 2019 February 5.
doi: 10.5812/compreped.82258.
Research Article
Epidemiology, Incidence, and Mortality of Leukemia in Children Early
Infancy to 14 Years Old of Age in South-Central Asia: A Global
Ecological Study
Zaher Khazaei 1, Elham Goodarzi 2, *, Hossein Ali Adineh 3, Yousef Moradi 4, Malihe Sohrabivafa 5, Isan
Darvishi 6 and Seyedeh Leila Dehghani 7
1Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran
2Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
3Department of Epidemiology and Biostatistics, Iranshahr University of Medical Sciences, Iranshahr, Iran
4Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Science, Tehran, Iran
5Department of Health and Community Medicine, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran
6Surgical Technology Department, School of Nursing and Midwifery, Shiraz University of Medical Sciences and Healthcare Services. Shiraz, Iran
7Behbahan Faculty of Medical Sciences, Behbahan, Iran
*Corresponding author: Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. Email: elhamgoodarzi.1370@yahoo.com
Received 2018 July 16; Revised 2018 September 03; Accepted 2018 October 07.
Abstract
Background: The cancer was considered the second cause of death from early infancy to 14 years of age after the inadvertent dam-
age. Also, leukemia was reported as the most common type of cancer in infants.
Objectives: The current study was aimed to evaluate the epidemiology, incidence, and mortality rates of leukemia from early in-
fancy to 14 years of age in South-Central Asia.
Methods: This is a descriptive cross-sectional study. In the current study, the incidence and mortality rates of leukemia
in South-Central Asia were determined. The data were extracted from a Cancer Global Project in 2012 available at
http://globocan.iarc.fr/Default.aspx.
Results: In South-Central Asia, 1514027 cases of cancer were recorded in 2012 in which 480267 cases (3.2%) were related to leukemia.
The highest incidence rates of leukemia were reported for Iran, Kazakhstan, Sri Lanka, and Uzbekistan with the ratio of 3.6, 3.2, and
3 cases per 100000 people, respectively compared with the lowest incidence rates in Bangladesh, and Bhutan with the ratio of 0.8
and 0.9 cases per 100000 people, respectively in under14-year-old infants.
Conclusions: Leukemia was reported as the most common type of cancer in infants, providing important information about pos-
sible changes of risk factors considering that its trend might help us to find critical ways so as to decrease the rate of cancer in
infants.
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1. Background
The cancer is considered the second cause of death
around the world, especially in the developed countries
after cardiovascular diseases (1, 2) and the third cause of
death in less-developed countries after cardiovascular dis-
eases and accidents (2). The rate of cancer was estimated at
< 1% of the total cancers from early infancy to 14-year-old
age group (6, 7).
The cancer was reported as one of the main causes of
death among the infants (8, 9). It was considered the sec-
ond cause of death from early infancy to 14 years of the age
after the inadvertent damages with the mortality rate of
0.41 deaths per 10000 infants (10).
The most common types of cancer, based on the rate of
incidence in infants, were reported as acute lymphoblastic
leukemia, central nervous system tumors, and lymphoma,
respectively constituting half of the total malignancies in
infants (7, 11). Leukemia was defined as the malignant
switch of hematopoietic precursor cells categorized into
lymphoid and myeloid lineages based on the type of the
cell, and acute or chronic condition of the disease (11, 12).
The etiology of infantile leukemia still remained to be de-
termined. The epidemiologic studies assessed the risk fac-
tors for leukemia, including environmental, genetic, and
infectious factors (13, 14).
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Leukemia in children can be generated by genetic fac-
tors such as Down syndrome, Fanconi anemia, Bloom syn-
drome, and Custman syndrome. Exposure to some medi-
cations such as alcohol and urea nitrogen and ionizing ra-
diation can also cause this disorder (15).
Thirty-two percent of infantile cancers are related to
leukemia (16). Furthermore, leukemia was indicated as
the most common type of malignancy in under 15-year-old
infants with the ratio of 40/1000000 people suggesting
some 30% of the overall cancers in infants (17, 18).
The acute leukemia was demonstrated in 80% of the in-
fants suffering from leukemia in the developed countries
with the incidence ratio of 34.3:1000000 people (19). The
incidence ratio of leukemia was ranged from 4 to 9 cases
per 1 million people in Europe. In addition, 20% to 25% of
all leukemia cancers diagnosed in under 15-year-old infants
accounted for ALM and CML with the rate of 300 to 350
cases in European Union countries annually. Also, the in-
cidence ratio of leukemia was ranged from 7.1 to 8.9 cases
per 1 million infants (20, 21). The lowest incidence rates of
leukemia were reported in Middle and Western Africa (be-
ing < 3:100000 in males and < 2:100000 in females) com-
pared with the highest incidence rates in Northern Amer-
ica and Australia (> 10:100000 in males and > 7:100000 in
females) (3).
The incidence rate of acute leukemia was estimated at
less than 3% of the total cancers significantly remarked ow-
ing to a high rate of mortality (8). The mortality ratio for
males and females were ranged from 1.3 to 6.3 and 1.1 to
3.8 per 100000 people, respectively. The low incidence and
mortality rates resulted from the lack of disease diagnosis
in South-Saharan Africa (3).
The treatment of these patients is done by two ap-
proaches. In the first approach, chemotherapy is used and
in the second approach, after the initial chemotherapy, a
stem cell transplant is used (15).
The data related to the incidence and mortality rates in
different populations might provide important informa-
tion about risk factors and possible changes.
2. Objectives
Thus the current study was aimed to evaluate the epi-
demiology, incidence, and mortality rates of leukemia
from early infancy to 14-year-old infants in South-Central
Asia.
3. Methods
This is a descriptive cross-sectional study. In the cur-
rent study, the incidence and mortality rates of leukemia
in South-Central Asia were determined. The data were ex-
tracted from a Cancer Global Project in 2012 available at
http://globocan.iarc.fr/Default.aspx.
3.1. Age-Specific Incidence Rates
The methods of estimation are country-specific and
the quality of the estimation depends upon the quality and
on the amount of the information available for each coun-
try. In theory, there are as many methods as countries and
because of the variety and the complexity of these meth-
ods, an overall quality score is almost impossible to estab-
lish for the incidence and mortality estimation. However,
an alphanumeric scoring system which independently de-
scribes the availability of the incidence and mortality data
was established at the country level. The combined score is
presented together with the estimates for each country to
provide a broad indication of the robustness of the estima-
tion. The methods to estimate the gender- and age-specific
incidence rates of cancer for a specific country fall into
one of the following broad categories according to prior-
ity order: (1) rates of the projects until 2012 (38 countries),
(2) most recent rates applied to 2012 population (20 coun-
tries), (3) estimated at national mortality by modeling, us-
ing incidence mortality ratios derived from recorded data
in country-specific cancer registries (13 countries), (4) es-
timated at national mortality estimates by modeling, us-
ing incidence mortality ratios derived from recorded data
in local cancer registries in neighboring countries (9 Eu-
ropean countries), (5) estimated at national mortality esti-
mates using modeled survival (32 countries), (6) estimated
at the calculated average of the local rates (16 countries),
(7) one cancer registry covering part of a country was used
as representative of the country profile (11 countries), (8)
age/gender-specific rates for "all cancers" were partitioned
using data on the relative frequency of different cancers
(by age and gender) (12 countries), and (9) the rates of
neighboring countries or registries in the same area (33
countries).
3.2. Age-Specific Mortality Rate
Depending on the degree of detail and accuracy of the
national mortality data, six methods were utilized in the
following order of priority: (1) rates of the projects until
2012 (69 countries), (2) most recent rates applied to 2012
population (26 countries), (3) estimated at the calculated
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average of regional rates (1 country), (4) estimated at na-
tional incidence estimates by modeling, using country-
specific survival (2 countries), (5) estimated at national in-
cidence estimates using modeled survival (83 countries),
and (6) the rates of neighboring countries or registries in
the same area (3 countries) (3).
4. Results
In 2012, South-Central Asia has reported 151407 cases
of cancer, of which 48067 (3.2%) are related to leukemia
(Figure 1). Of these, 28870 (1/4%) were in men and 28498
(6.3%) in women. India (32532 cases), Pakistan (4609 cases),
and Iran (3926 cases) had the highest reported incidence
rates. Iran (5.8 out of 100000) and Pakistan (5.7 out of
100000) had the highest incidence, which the highest inci-
dence in women related to Kazakhstan and in men related
to Iran. In South-Central Asia in 2012, 102440 deaths were
reported due to total cancers, of which 4470 (3.9%) died due
to leukemia. India (26712 cases), Pakistan (4180 cases), and
Iran (3064 cases) had the highest death rates for leukemia,
with the highest death rates for women (3.8 per 100000)
and the highest death rates for men (4.5 out of 100000) in
Iran (Table 1 and Figure 1).
In the study of incidence rates in the age group un-
der 14 years of age, in both sexes, Iran and Kazakhstan had
the highest incidence of leukemia in the age group of 0
- 14 years, with the incidence rate of 3.6 in 100000, the
highest incidence in girls was observed in Kazakhstan (3.4
in 1000000 people) and the boys in the Maldives (4.4 in
100000) (Table 2 and Figure 2). In the study of mortal-
ity rate in the age group under 14 years, Maldives (2.5 in
100000) and Nepal (3.2 in 100000) had the highest mor-
tality rates, with the highest death rates in girls from Iran
and Kazakhstan (8/1 in 1000000 people) and in boys in the
Maldives (4.4 in 100000) (Table 2, Figure 2 and 3).
5. Discussion
Prominent progress was obtained in treating infantile
cancers during the last decades, however, leukemia was re-
ported as one of the most important factors in infantile
mortality (22). Massive therapeutic costs, hospitalization
length, and psychological problems indicated the heavy
burden of the socio-economic situation of leukemia. Ap-
proximately, 10.4 million dollars are paid so as to treat
acute leukemia in infants in the United States annually
(23).
The highest ratio of incidence in under 14-year-old in-
fants in South-Central Asia was reported in Iran, Kaza-
khstan, Sri Lanka, and Uzbekistan with 3.6, 3.6, 3.2, and 3
cases per 100000 people, respectively. Moreover, the high-
est ratio of mortality under 14-year-old infants in South-
Central Asia was reported in Maldives, Nepal, and Uzbek-
istan with 2.5, 2.3, and 2.2 cases per 100000 people, respec-
tively.
Only 10% of the cases of childhood cancers have been
clinically and epidemiologically distinguished and no spe-
cific etiology has been identified in 90% of the cases. It
seems that childhood leukemia, as well as other cancers,
are multifactorial disorders in which environmental and
genetic factors play important roles (13).
About 59014 new cases of leukemia with a mortality
rate of 37010 were estimated in 2013, which might signifi-
cantly develop in Northern America and New Zealand com-
pared with the insignificant development in Europe to-
ward Asia region and less-developed countries.
The different rates of mortality of leukemia in the de-
veloped countries rather than other countries could be
due to different healthcare systems, production and acces-
sibility of effective medications, and stem cell implanta-
tion for some types of leukemia (24).
The estimates of incidence related to leukemia from
early infancy to 14 years of age in Eastern Asia, including
China and Japan, were 2.6, and 3.3 cases per 100000 peo-
ple, respectively. The estimates for South-Eastern Asia, in-
cluding Philippine and Vietnam, were 3.4 and 2.6 cases per
100000 people, respectively. Also, the estimates for West-
ern Asia, including Azerbaijan, Bahrain, Iraq, and Saudi
Arabia, were 3.4, 4.7, 4.1, and 3.9 cases per 100000 people,
respectively (3). Van den Broek et al. estimated the overall
incidence rate of leukemia in the Netherlands for all age
groups as 3.8 cases per 100000 and with the ratios of 5.1,
and 3.2 cases per 100000 people for males and females, re-
spectively (25).
The rate of incidence of leukemia in Europe was esti-
mated at 3.8 cases per 100000 people for all age groups
(26). The rate of incidence was stable in the United States
from 1987 to 2001 (27). The incidence trend of leukemia was
increased in Denmark from 1943 to 2003 (28).
Healey et al. reported the standardized incidence rate
of leukemia in Canada as 4.01 cases per 100000 people (29).
The rate of incidence of acute leukemia was ranged from
1.93 to 3.51 cases per 100000 people from 2004 to 2007. In
addition, 2811 cases of cancer were registered for Iran in
2009 with the rates of 1075 and 1736 cases for females and
males, respectively. The standardized incidence rates of
leukemia for females and males were estimated at 3.76 and
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Figure 2. Incidence rate of leukemia in countries of South-Central Asia in children 0 - 14 years
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Table 2. Incidence and Mortality of Leukemia in South-Central Asia by Country in 0 - 14 Years Old
Papulation
Incidence Rate in 0 - 14 Years Mortality Rate in 0 - 14 Years
Boy Girl Both Sex Boy Girl Both Sex
Afghanistan 2.2 1.4 1.8 2.0 1.3 1.6
Bangladesh 1.0 0.5 0.8 0.8 0.5 0.6
Bhutan 1.9 - 0.9 1.9 - 0.9
India 2.8 1.8 2.3 1.7 1.1 1.4
Iran 4.3 2.9 3.6 1.7 1.8 2.1
Kazakhstan 3.9 3.4 3.6 2.3 1.8 2.0
Kyrgyzstan 2.0 1.5 1.8 1.6 1.0 1.3
Maldives 4.8 - 2.5 4.8 - 2.5
Nepal 3.2 1.8 2.5 2.9 1.6 2.3
Pakistan 3.2 1.5 2.4 2.6 1.2 1.8
Sri Lanka 3.8 2.5 3.2 2.4 1.6 2.0
Tajikistan 1.2 1.2 1.2 1.1 1.0 1.0
Turkmenistan 2.9 2.8 2.1 2.1 1.9 2.0
Uzbekistan 3.7 2.2 3.0 2.8 1.7 2.2
5.09 cases per 100000 people, respectively (15, 29).
In the study of Hjalgrim et al. performed on the spe-
cific incidence of leukemia based on age and gender in in-
fants in 5 Scandinavian countries, including Sweden, Den-
mark, Norway, Finland, and Ice Land, they estimated the in-
cidence rate of acute lymphoblastic leukemia during the
five 4-year periods from 3.84 to 4.03 cases per 100000 peo-
ple with the annual mean of 0.22% (30).
The incidence rate of acute leukemia in Iran ranged
from 1.93 to 3.51 cases per 100000 people from 2003 to
2006. Moreover, 2811 cases with leukemia were registered
from Iran in 2008 with the rates of 1075 and 1736 cases for fe-
males and males, respectively. The standardized incidence
rates of leukemia for females and males were estimated at
3.76 and 5.09 cases per 100000 people, respectively (15, 29).
The incidence ratio of acute lymphoblastic leukemia in un-
der 15-year-old infants was reported in Fars province with
32.6 cases per 1 million infants with the prevalence of 57.5%
and 42.5% in males and females, respectively (31).
Leukemia is often accompanied by fatigue, fever, bleed-
ing, chest pain, and splenomegaly. Therefore, leukemia
is one of the common causes of child mortality. Identify-
ing effective factors and controlling them and the focus of
screening programs on specific subtypes can lead to early
detection and effective treatment of the patients (32).
The highest mortality ratios in under 14-year-old in-
fants in South-Central Asia were reported in Maldives,
Nepal, and Uzbekistan as 2.5, 2.3, and 2.2 cases per 100000
people, respectively compared with the lowest mortality
ratios in Bangladesh, Bhutan, and Tajikistan as 0.6, 0.9, and
1 case per 100000 people, respectively.
The highest mortality ratios from early infancy to 14
years of age in Eastern Asia were reported in China, and
Japan with 2.3, and 0.6 cases per 100000 people, respec-
tively. Also, the highest mortality ratios from early infancy
to 14 years of age in South-Eastern Asia were reported in
Philippine and Vietnam with 2.2, and 2 cases per 100000
people, respectively. In addition, the highest mortality ra-
tios from early infancy to 14 years of age in Western Asia
were reported in Azerbaijan, Bahrain, Iraq, and Saudi Ara-
bia with 2.3, 1.1, 2.9, and 2.3 cases per 100000 people, respec-
tively (3).
Lack of adequate space, proper nutrition and para
clinical useful facilities for detecting complications of
chemotherapy drugs in addition to cultural and health
problems as well as family poverty can increase the mor-
tality rate of this disease. Since the prevalence of factors af-
fecting leukemia varies corresponding the time and popu-
lation, the study of effective factors in different regions can
lead to more accurate identification of factors to reduce
the incidence and mortality of the disease.
5.1. Conclusion
Monitoring cancer incidence trend is considered one
of the most important branches of cancer supervision
system. Evaluation of cancer incidence rates could pro-
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Figure 3. Mortality rate of leukemia in countries of South-Central Asia in children 0 - 14 years
vide important information about risk factors and possi-
ble changes that help us to find ways so as to reduce the in-
cidence of cancer in infants. Thus propagating of screen-
ing programs, application of correct and on-time diagno-
sis and treatment of the disease in infants could decline the
rate of mortality in these patients.
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Table 1. Incidence and Mortality of Leukemia in South-Central Asia by Country in All Group Ages
Incidence Mortality 5-Year Prevalence
No. (%) ASR, W No. (%) ASR, W No. (%) Prop
Afghanistan
Male 433 (4.7) 2.8 417 (5.2) 2.8 358 (2.2) 3.8
Female 253 (2.8) 1.8 238 (3.2) 1.8 201 (0.8) 2.3
Both Sex 609 (3.5) 2.3 655 (4.2) 2.3 559 (1.3) 3.1
Bangladesh
Male 1213 (2.0) 1.7 1121 (2.3) 1.7 935 (0.9) 1.7
Female 862 (1.4) 1.3 810 (1.9) 1.2 775 (0.5) 1.5
Both Sex 2075 (1.7) 1.5 1931 (2.1) 1.4 1710 (0.7) 1.6
Bhutan
Male 10 (4.1) 2.7 8 (3.8) 2.2 20 (5.1) 6.9
Female 6 (2.8) 1.9 4 (2.4) 1.2 8 (1.9) 3.2
Both Sex 16 (3.5) 2.3 12 (3.2) 1.7 28 (3.5) 5.2
India
Male 19619 (4.1) 3.3 16068 (4.5) 2.7 13954 (2.1) 3.1
Female 12913 (2.4) 2.3 10644 (3.3) 1.9 10088 (0.9) 2.3
Both Sex 32532 (3.2) 2.8 26712 (3.9) 2.3 24042 (1.3) 2.7
Iran
Male 2338 (5.2) 6.9 1822 (6.1) 5.4 2268 (2.9) 7.7
Female 1588 (4.0) 4.7 1242 (5.3) 3.8 1620 (1.8) 5.6
Both Sex 3926 (4.6) 5.8 3064 (5.7) 4.6 3888 (2.3) 6.7
Kazakhstan
Male 497 (2.7) 6.9 368 (2.9) 5.3 458 (1.5) 8.0
Female 440 (2.0) 4.8 323 (3.0) 3.4 381 (0.7) 5.9
Both Sex 937 (2.3) 5.7 691 (2.9) 4.1 839 (1.0) 6.9
Kyrgyzstan
Male 93 (3.5) 4.0 83 (4.0) 3.7 83 (2.0) 4.5
Female 65 (2.1) 2.5 56 (3.0) 2.2 61 (0.8) 3.1
Both Sex 158 (2.7) 3.2 139 (3.5) 2.9 144 (1.3) 3.8
Maldives
Male 4 (3.5) 2.8 4 (5.0) 2.8 4 (2.1) 3.3
Female 0 (0.0) 0.0 0 (00) 00 0 (0.0) 0.0
Both Sex 4 (1.8) 1.4 4 (3.1) 1.4 4 (0.8) 1.6
Nepal
Male 522 (6.2) 4.0 497 (7.2) 4.0 410 (2.9) 4.2
Female 319 (3.1) 2.3 303 (4.1) 2.2 289 (1.2) 2.8
Both Sex 841 (4.5) 3.1 800 (5.6) 3.0 699 (1.8) 3.5
Pakistan
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Male 2872 (4.5) 3.3 2598 (5.4) 3.1 2450 (2.1) 4.1
Female 1737 (2.1) 2.2 1582 (3.0) 2.0 1728 (0.8) 3.0
Both Sex 4609 (3.1) 2.8 4180 (4.1) 2.6 4178 (1.2) 3.5
Sri Lanka
Male 578 (5.7) 5.3 465 (6.9) 4.2 592 (3.3) 7.6
Female 496 (3.7) 4.2 401 (5.6) 3.3 439 (1.3) 5.4
Both Sex 1074 (4.5) 4.7 866 (6.2) 3.7 1031 (2.0) 6.5
Tajikistan
Male 7.5 (2.9) 2.3 64 (1.3) 2.0 64 (1.6) 3.0
Female 46 (1.6) 1.4 39 (2.1) 1.3 38 (0.6) 1.6
Both Sex 121 (2.2) 1.8 103 (2.6) 1.6 102 (1.0) 2.3
Turkmenistan
Male 77 (2.6) 3.2 64 (3.0) 2.8 59 (1.3) 3.3
Female 66 (2.1) 2.7 54 (2.9) 2.2 62 (0.9) 3.3
Both Sex 143 (2.4) 2.9 118 (3.0) 2.5 121 (1.1) 3.3
Uzbekistan
Male 529 (5.4) 4.1 449 (6.0) 3.5 509 (3.3) 5.2
Female 406 (3.2) 3.0 346 (4.7) 2.6 370 (1.2) 3.6
Both Sex 535 (4.1) 3.5 795 (5.3) 3.1 879 (1.9) 4.4
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